Med. praxi. 2011;8(2):50-53

Management of hypertension in ischaemic heart disease

prof.MUDr.Jiří Vítovec, CSc., FESC, prof.MUDr.Jindřich Špinar, CSc., FESC

¹ 1. interní kardioangiologická klinika FN u sv. Anny a Lékařská fakulta MU Brno

² Interní kardiologická klinika FN Brno a Lékařská fakulta MU, Brno

Hypertension and ischaemic heart disease are very common conditions, with proper blood pressure control being essential for both

primary and secondary prevention of ischaemic heart disease. In terms of primary prevention, it is recommended to control blood pressure

effectively, i. e. to maintain the pressure below 140/90 mm Hg; for patients in secondary prevention, it has been recommended to

keep it below 130/85 mm Hg. However, recent evidence suggests that appropriate systolic blood pressure for ischaemic patients is

130–139 mm Hg and their diastolic blood pressure should not drop below 90 mm Hg. The mainstay of hypertension management in

patients with ischaemic heart disease is the use of renin-angiotensin system blockers, i. e. ACE inhibitors or sartans, supplemented with

beta blockers and/or calcium channel blockers, antiplatelet treatment and hypolipidaemic treatment.

Keywords: hypertension, ischaemic heart disease, ACE inhibitors, sartans, beta blockers, calcium channel blockers

Published: February 22, 2011  Show citation